Catholic Medical Quarterly Vol 76 (4) November 2026
A timely warning about end of life care practices
Dear Sir,
I am a barrister practising, inter alia, in the area of medical law, court of protection and capacity law, inquests and similar.
I read with interest the article by Professor Patrick Pullicino entitled End of Life “Care”, euthanasia and assisted dying in the May edition of CMQ.
It gives us a timely warning about certain current end of life care (“EOLC”) practices within the health service which are, or should be, of serious concern to all.
A great many such cases come to my desk in my legal practice and, in that respect, I am bound to say that, in my experience, this timely warning is necessary and, if anything, long overdue.
The background is the Liverpool Care Pathway (“LCP”) which, despite being a seriously – and in my view obviously – retrograde step in EOLC, was endorsed not only by the LCP committee, itself, but by the Department of Health, numerous clinicians and palliators, and even by some Catholic agencies like the late Anscombe Bioethics Centre (an otherwise excellent organisation now sadly in demise).
Whilst the original aims may have been benevolent, the reality is that
the LCP encouraged the use of what can best be described as an algorithmic
“tick box” approach to clinical decision-making which is entirely
inappropriate let alone in EOLC. Palliation is a medical and nursing art
not amenable to algorithmic solutions.
Medicine and nursing are both
arts and sciences, combined in the person of the clinician, whose
limitations are clinical, on the one hand, and ethical, on the other.
The chief protection for the general public, therefore, is, first and foremost the Hippocratic tradition of beneficence and non-maleficence and all the medical ethical protocols that flow therefrom.
Why is this important? Because doctors and nurses are, of all professions, best placed to terminate a life and to conceal the fact. Therefore, regulating the ethics of those professions becomes of supreme importance to the general public.
We have very salutary historical examples of what happens to those professions when their ethical mandates are allowed to be eroded.
Supplementing these criteria, and, indeed, subsumed within them, both legally and clinically, is the obvious importance of consulting with family and immediate carers. This obvious necessity was, as the professor rightly points out, reinforced by the 2013 UK Supreme Court case of Aintree University Hospitals NHS Foundation Trust v James [2013] UKSC 67 per Baroness Hale.
The 2013 Neuberger Report called for an end to the LCP to the surprise of some but not to those who had seen its ill effects.
Despite this, a mentality had embedded itself and many EOLC pathways are continuing the LCP methodology and medications, albeit in an alternative fashion.
That deaths are being caused unjustly thereby is clear to any with eyes to see, but no statistics have been published because the fact is not usually mentioned on death certificates.
Sadly, we are more and more seeing, today, increasing numbers of cases arising in the service of clinical negligence (or worse) and iatrogenic practice.
The more recent NICE clinical care guidance, NG31, produced by Professor Sam Ahmedzai’s committee, is a very good attempt to make up for the deficiencies of the LCP and to restore proper clinical judgement to EOLC.
The problem is that it is not being used sufficiently widely or properly and a lingering “LCP mentality” persists since “tick box” medicine is easier to undertake and bureaucratically easier to justify, even when it is not good medicine.
As the professor asserts, the chief mechanism is already a dangerous one: a combination of opiate (morphine) and benzodiazepine (midazolam) delivered by syringe driver, with incremental doses being increased by nurses in accordance with anticipated prescribing.
This sometimes useful but nevertheless potentially lethal combination is now the principal way in which the life of a patient ends by being shortened. Midazolam is said to reduce the anxiety and agitation that may be associated with dying and is therefore regarded by many as an obligatory component of the EOLC pathway even when agitation and pain are not present.
Midazolam often causes confusion but that is all too often managed, not by decreasing but by increasing, the dosage, thus augmenting the danger of a fatal respiratory suppression, the result of the combination with opiates.
Midazolam often renders the patient unable to participate in discussions, declare their need for fluids and nutrition and indeed prevents them from being consulted at all.
On top of that, family and other non-professional carers are all too often ignored, swept aside or even threatened and abused.
This flatly contradicts the legal stipulations of the Mental Capacity Act 2005 which require, firstly, the option least restrictive of the patient (s.1(6)) and, secondly, consultation with family and carers to determine best interests (s.4), best interests being wider than clinical criteria alone (see the case of Aintree cited above).
Rendering a patient incommunicative by midazolam flatly breaches those provisions, as does ignoring or sidelining his or her family, and yet it is now all too often done in EOLC.
I repeat: it is unlawful.
And I need hardly add that, absent authorisation from the court, it is even more unlawful deliberately to shorten the life of a patient. That is an illegal homicide and punishable by life imprisonment.
For these reasons and others, the professor’s warning is a timely one and steps must be taken to ensure that the dangers he lists are obviated and prevented, upon pain of disciplinary sanction, if necessary.
The safety of the public demands no less.
Yours sincerely, James Bogle, Barrister